IBC Life Sciences

The leading provider of scientific, technological and business information

Main menu

My IBC

Login form

Sign Up

Next Generation Protein Therapeutics Summit

CSS

CSS - agenda

conference titles

IBC's 5th Annual Beyond Antibodies - Novel Scaffolds and Preclinical-Clinical Progress IBC's 4th Annual Protein Engineering & Design - Technology and Engineering to Improve Drug-Like Properties
IBC's 1st Annual Immunogenicity of Biologics - Preclinical and Clinical Strategies IBC's 1st Annual Crossing the Barriers - Molecular Targeting, Intracellular Approaches and Delivery

Event Information

Cross-Fertilize Ideas from Different Disciplines and Turn Promising Molecules into Products

June 21 - 23, 2010 · San Francisco Airport Marriott · Burlingame, CA

Document Title

Scientific Advisory Board

Scientific Advisory Board

Scientific Advisory Board

H. Kaspar Binz, Ph.D., Vice President, Technology and Co-Founder, Molecular Partners, Switzerland

Jonathan Davis, Ph.D., Principal Scientist, Protein Design, Adnexus, a Bristol-Myers Squibb Company

Jonathan G. Drachman, M.D., Vice President, Translational Medicine, Seattle Genetics, Inc.

Robert Mabry, Ph.D., Senior Scientist, Antibody Engineering, Adimab, Inc.

Arne Skerra, Ph.D., Professor of Biological Chemistry, Technical University of Munich

Paul Watt, Ph.D., Vice President, Research, Phylogica Ltd., Australia

David S. Wilson, Ph.D., Vice President of R&D, Arana Therapeutics

Michael Wittekind, Ph.D., Executive Director, Protein Science - Amgen Washington, Amgen, Inc.

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group. | Phone: 800.390.4078 | Email: reg@ibcusa.com

Powered by Interactive Agency Janmedia Interactive, Inc.